These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 25141976)

  • 41. A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.
    He J; Starr CG; Wimley WC
    Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):8-15. PubMed ID: 25268681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three new antimicrobial peptides from the scorpion Pandinus imperator.
    Zeng XC; Zhou L; Shi W; Luo X; Zhang L; Nie Y; Wang J; Wu S; Cao B; Cao H
    Peptides; 2013 Jul; 45():28-34. PubMed ID: 23624072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.
    Mouton JW; Ambrose PG; Canton R; Drusano GL; Harbarth S; MacGowan A; Theuretzbacher U; Turnidge J
    Drug Resist Updat; 2011 Apr; 14(2):107-17. PubMed ID: 21440486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helix.
    Nepal M; Thangamani S; Seleem MN; Chmielewski J
    Org Biomol Chem; 2015 Jun; 13(21):5930-6. PubMed ID: 25925008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural studies of a peptide with immune modulating and direct antimicrobial activity.
    Wieczorek M; Jenssen H; Kindrachuk J; Scott WR; Elliott M; Hilpert K; Cheng JT; Hancock RE; Straus SK
    Chem Biol; 2010 Sep; 17(9):970-80. PubMed ID: 20851346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AApeptides as a new class of antimicrobial agents.
    Niu Y; Wu H; Li Y; Hu Y; Padhee S; Li Q; Cao C; Cai J
    Org Biomol Chem; 2013 Jul; 11(26):4283-90. PubMed ID: 23722277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.
    Knappe D; Piantavigna S; Hansen A; Mechler A; Binas A; Nolte O; Martin LL; Hoffmann R
    J Med Chem; 2010 Jul; 53(14):5240-7. PubMed ID: 20565063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Augmentation of the antibacterial activities of Pt5-derived antimicrobial peptides (AMPs) by amino acid substitutions: Design of novel AMPs against MDR bacteria.
    Wang Y; Cui P; Zhang Y; Yang Q; Zhang S
    Fish Shellfish Immunol; 2018 Jun; 77():100-111. PubMed ID: 29567140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The therapeutic potential of host-defense antimicrobial peptides.
    Sitaram N; Nagaraj R
    Curr Drug Targets; 2002 Jun; 3(3):259-67. PubMed ID: 12041739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane active antimicrobial activity and molecular dynamics study of a novel cationic antimicrobial peptide polybia-MPI, from the venom of Polybia paulista.
    Wang K; Yan J; Dang W; Liu X; Chen R; Zhang J; Zhang B; Zhang W; Kai M; Yan W; Yang Z; Xie J; Wang R
    Peptides; 2013 Jan; 39():80-8. PubMed ID: 23159560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria.
    Batoni G; Maisetta G; Esin S
    Biochim Biophys Acta; 2016 May; 1858(5):1044-60. PubMed ID: 26525663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The growing burden of antimicrobial resistance.
    Hawkey PM
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i1-9. PubMed ID: 18684701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome.
    Krizsan A; Volke D; Weinert S; Sträter N; Knappe D; Hoffmann R
    Angew Chem Int Ed Engl; 2014 Nov; 53(45):12236-9. PubMed ID: 25220491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial peptides: new drugs for bad bugs?
    Steckbeck JD; Deslouches B; Montelaro RC
    Expert Opin Biol Ther; 2014 Jan; 14(1):11-4. PubMed ID: 24206062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effects and mechanisms of physiological conditions on the activity of enantiomeric forms of an α-helical antibacterial peptide against bacteria.
    Huang J; Hao D; Chen Y; Xu Y; Tan J; Huang Y; Li F; Chen Y
    Peptides; 2011 Jul; 32(7):1488-95. PubMed ID: 21664394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the in vivo significance of bacterial resistance to antimicrobial peptides.
    Bauer ME; Shafer WM
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3101-11. PubMed ID: 25701234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial peptides: premises and promises.
    Reddy KV; Yedery RD; Aranha C
    Int J Antimicrob Agents; 2004 Dec; 24(6):536-47. PubMed ID: 15555874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.
    Li C; Haug T; Styrvold OB; Jørgensen TØ; Stensvåg K
    Dev Comp Immunol; 2008; 32(12):1430-40. PubMed ID: 18656496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antimicrobial peptides: a new way to treat bacterial infections].
    Igaz P
    Orv Hetil; 2001 Jan; 142(4):169-71. PubMed ID: 11232153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Calculated antibiotic therapy in gastroenterologic infections].
    Braun RW
    Praxis (Bern 1994); 2003 Aug; 92(33):1343-9. PubMed ID: 14502790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.